Skip to content

Transabdominal Chest Drains to Reduce Postoperative Pain Following Minimally Invasive Esophagectomy - DISCUSS-Trial

Transabdominal Chest Drains to Reduce Postoperative Pain Following Minimally Invasive Esophagectomy - DISCUSS-Trial - DISCUSS-PILOT

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00036801
Enrollment
24
Registered
2025-05-26
Start date
2025-06-18
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C15.5 C16.0

Interventions

Group 1: Transabdominal chest drainage after Iwor-Lewis in prospective recruited patients Group 2: Intercostal chest drainage after Iwor-Lewis from a historical cohort

Sponsors

Universitätsklinikum Ulm, Klinik für Allgemein- und Viszeralchirurgie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • elective RAMIE with intrathoracic esophagogastrostomy (Ivor-Lewis) • American Society of Anesthesiologists (ASA) score = III • Eastern Cooperative of Oncology Group (ECOG) status = II • patient suitable for both surgical techniques • ability of subject to understand character and individual consequences of the clinical trial • written informed consent

Exclusion criteria

Exclusion criteria: emergency surgery, ASA IV, ECOG > II, chronic pain syndromes requiring routine analgesic therapy, participation in an interventional trial that affects the outcome, and impaired mental state that precludes admission

Design outcomes

Primary

MeasureTime frame
Intensity of postoperative pain according to NRS at postoperative day three

Secondary

MeasureTime frame
• Postoperative intervention rate (CT/ultrasound-guided punctures of an intra-abdominal collections • Reoperation rate • Surgery – specific morbidity (within the hospital stay and 30 days postoperatively) o Postoperative complications classified according to the Clavien-Dindo classification. • Mortality (within the hospital stay and 30 days postoperatively) • Length of IMC/ICU stay. • Length of hospital stay. • Additional interventional therapies required (e.g. endoscopic procedures, insertion of a gastric tube or a feeding tube

Countries

Germany

Contacts

Public ContactBenjamin Müssle

Universitätsklinikum Ulm, Klinik für Allgemein- und Viszeralchirurgie

benjamin-moritz.muessle@uniklinik-ulm.de+49 73150053500

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026